Xcout Intel
BioMed Partners
BioMed Partners (BiomedVC) is a venture capital firm that invests in early-stage life science startups in continental Europe, with a focus on Switzerland and Germany. The firm provides initial investments at the Seed and Series A stages to help entrepreneurs translate academic scientific innovations into venture-backed biotech companies developing therapeutics for high-unmet medical needs.
Subscribe to see BioMed Partners’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BioMed Partners at a glance
BioMed Partners is a venture capital company. Xcout tracks 12 named people at BioMed Partners, including Stefan Fäs (CFO, Partner).
BioMed Partners leadership
- Stefan FäsCFO, Partner
- Dr. Aristotelis NastosManaging Partner
- Dr. Markus HosangManaging Partner
- Dr. Michael WackerManaging Partner
- Dr. Valentin PiëchManaging Partner
- Thomas MöllerManaging Partner
6 more named people on record for BioMed Partners, with roles, board committees and tenure — see the full roster →
BioMed Partners competitors
A few of BioMed Partners's closest competitors — see the full list of competitors and alternatives →
AdBio Partners is a venture capital firm that invests in and develops early-stage life sciences and biotech startups across Europe. The company partners with academic institutions and scientific founders to fund breakthrough medical discoveries and therapeutic innovations.
VP Venture Partners is a private venture capital firm based in Zurich, Switzerland, that supports early-stage life science companies in Europe.
BioMed Ventures is a life science venture capital firm that operates as an investment arm of BioMed Realty. The firm focuses on investing in early- and growth-stage companies within the biotechnology and medical sectors.
Biovance Capital is a venture capital firm that invests in early-stage, seed, and Series A biopharmaceutical companies across Europe. The firm focuses on supporting the development of transformational medical treatments and building companies across various therapeutic areas and modalities.
Ventura BioMed Investors is a venture capital firm focusing on early-stage life science and biomedicine investments within Europe.
Biovision Ventures is a venture capital firm that invests in early-stage companies focusing on therapeutics, medtech, and bio-IT within the US and Europe. The firm targets private companies developing novel platform-based therapies and medical software solutions, typically participating from Series Seed to Series B financing rounds.
Get BioMed Partners's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about BioMed Partners? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BioMed Partners in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access